 
Class of 2023
 Go Back | | Session Title: | | Cardiovascular - Cardiac Drugs (CHF) | | | Teaching Hours: | | Teaching and Learning Methods | Total Scheduled Hours = 1
Lecture = 1 | | Description: | | | | Keywords: | | Translational Medical Research |
| Blueprint ID | Learning Objectives | | 9322 | Explain and describe the pharmacology and how the following different classes of drugs improve the symptoms associated with heart failure, and identify contraindications of: (i) ACE inhibitors, ARBs and neprilysin inhibitor (ii) Nitroprusside or combination of hydralazine and nitrates, (iii) Cardiac glycosides, (iv) Beta-blockers, (v) Ivabradine (vi) Sodium-Glucose Cotransporter-2 (SGLT2) inhibitors, (vii) Phosphodiesterase inhibitors | | 11811 | Explain how translational research was used to develop new pharmacological agents for the treatment of heart failure | | |
| Blueprint ID | Course Goals | | 7425 | Describe the pathophysiology of a variety of chronic illness
Linked Program Competencies
To This Course Goal: me-6 | | me-6 | Medical Expert
Apply knowledge of the clinical, socio-behavioural, and fundamental biomedical sciences relevant to a clinical problem. |
| DYSPNEA | | GENERALIZED EDEMA | | PLEURAL EFFUSION | | Medical Expert |
| | |
|